ADPT Adaptive Biotechnologies
Which ETFs hold ADPT? Adaptive Biotechnologies is held by 1 fund tracked by ETFpeek.
HealthcareDiagnostics & Research
$26.64
+53.5% 1y
$12.0052-week range$30.74
Market cap
$4.3B
3-month
+18.0%
CEO
Mr. Chad M. Robins M.B.A.
Revenue · last 4 qtrs (+21.5% YoY)
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Provider
Currently Held By
Not held by the selected provider.
Insider Activity
last 90 daysNet flow (90d):−$4.7M·23 BUY / 41 SELL·score ≥ 40
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 1 Oct 2026 | Francis Lo Chief People Officer | SELL | Unknown | 18,698 | $535K | 50 |
Net flow (90d):−$4.7M·23 BUY / 41 SELL·showing all trades
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 29 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 29 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $336K | 0 |
| 28 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 28 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $338K | 0 |
| 27 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 27 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $324K | 0 |
| 26 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 26 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $309K | 0 |
| 23 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 23 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $297K | 0 |
| 22 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 22 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $291K | 0 |
| 21 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 21 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $302K | 0 |
| 20 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 20 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $291K | 0 |
| 19 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 19 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $286K | 0 |
| 16 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 16 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $288K | 0 |
| 15 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 15 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $304K | 0 |
| 14 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 14 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $305K | 0 |
| 13 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 13 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $303K | 0 |
| 12 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 12 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $303K | 0 |
| 9 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 9 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $314K | 0 |
| 8 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 8 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $305K | 0 |
| 7 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 7 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $314K | 0 |
| 6 Oct 2026 | Susan Bobulsky Chief Commercial Officer of MRD | SELL | Unknown | 6,444 | $193K | 0 |
| 6 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 6 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 4 tranches | $330K | 0 |
| 5 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 5 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $347K | 0 |
| 2 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 2 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 | $334K | 0 |
| 1 Oct 2026 | Francis Lo Chief People Officer | SELL | Unknown | 26,792 2 tranches | $758K | 50 |
| 1 Oct 2026 | Julie Rubinstein President & COO | BUY | Option Exercise | 11,881 | $144K | 0 |
| 1 Oct 2026 | Julie Rubinstein President & COO | SELL | Unknown | 11,881 2 tranches | $333K | 0 |
| 1 Oct 2026 | Francis Lo Chief People Officer | BUY | Option Exercise | 17,415 2 tranches | $144K | 0 |
| 26 Aug 2026 | Katey Einterz Owen Director / Other | SELL | Unknown | 9,615 | $250K | 0 |
| 10 Aug 2026 | Susan Bobulsky Chief Commercial Officer of MRD | SELL | Unknown | 3,000 | $75K | 30 |
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
Trade History
3 trades| Date | Fund | Direction | Shares Changed | % Δ ETF | % Δ Position |
|---|---|---|---|---|---|
| 10 Jul 2026 | ARKG | SELLReduced | -108,120 | -0.01% | 5.77% |
| 9 Jul 2026 | ARKG | SELLReduced | -32,771 | -0.08% | 1.72% |
| 8 Jul 2026 | ARKG | SELLReduced | -72,324 | -0.11% | 3.62% |
| No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal. | |||||